Century Therapeutics (IPSC) Competitors

Century Therapeutics (NASDAQ:IPSC) and Checkpoint Therapeutics (NASDAQ:CKPT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability.

Do institutionals and insiders hold more shares of IPSC or CKPT?

50.2% of Century Therapeutics shares are owned by institutional investors. Comparatively, 22.0% of Checkpoint Therapeutics shares are owned by institutional investors. 6.8% of Century Therapeutics shares are owned by insiders. Comparatively, 2.1% of Checkpoint Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Which has more volatility and risk, IPSC or CKPT?

Century Therapeutics has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. Comparatively, Checkpoint Therapeutics has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500.

Do analysts prefer IPSC or CKPT?

Century Therapeutics presently has a consensus price target of $5.00, suggesting a potential upside of 811.74%. Checkpoint Therapeutics has a consensus price target of $4.33, suggesting a potential upside of 7.53%. Given Century Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Century Therapeutics is more favorable than Checkpoint Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Century Therapeutics	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Checkpoint Therapeutics	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is IPSC or CKPT more profitable?

Checkpoint Therapeutics has a net margin of 0.00% compared to Century Therapeutics' net margin of -4,837.73%. Checkpoint Therapeutics' return on equity of 0.00% beat Century Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Century Therapeutics	-4,837.73%	-61.66%	-31.78%
Checkpoint Therapeutics	N/A	N/A	-659.07%

Does the media prefer IPSC or CKPT?

In the previous week, Century Therapeutics had 20 more articles in the media than Checkpoint Therapeutics. MarketBeat recorded 22 mentions for Century Therapeutics and 2 mentions for Checkpoint Therapeutics. Checkpoint Therapeutics' average media sentiment score of 0.96 beat Century Therapeutics' score of 0.28 indicating that Checkpoint Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Century Therapeutics	Neutral
Checkpoint Therapeutics	Positive

Does the MarketBeat Community favor IPSC or CKPT?

Checkpoint Therapeutics received 141 more outperform votes than Century Therapeutics when rated by MarketBeat users. However, 68.97% of users gave Century Therapeutics an outperform vote while only 67.04% of users gave Checkpoint Therapeutics an outperform vote.

Company	Underperform	Outperform
Century Therapeutics	Outperform Votes 40 68.97%	Underperform Votes 18 31.03%
Checkpoint Therapeutics	Outperform Votes 181 67.04%	Underperform Votes 89 32.96%

Which has stronger valuation and earnings, IPSC or CKPT?

Checkpoint Therapeutics has lower revenue, but higher earnings than Century Therapeutics. Checkpoint Therapeutics is trading at a lower price-to-earnings ratio than Century Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Century Therapeutics	$6.59M	7.16	-$136.67M	-$1.63	-0.34
Checkpoint Therapeutics	$47K	4,187.17	-$51.85M	-$1.84	-2.19

Summary

Century Therapeutics beats Checkpoint Therapeutics on 12 of the 18 factors compared between the two stocks.